A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2004
12/23/2004	US20040259952 Formulations for oral administration of cromolyn sodium
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259921 EP4 receptor selective agonists in the treatment of osteoporosis
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/23/2004	US20040259865 Laxative; adenosine receptor antagonist
12/23/2004	US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity
12/23/2004	US20040259846 Desolventizing by spray drying; bone disorders, osteoporosis; Paget's disease; osteoarthritis
12/23/2004	US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259779 Novel neurotrophic factors
12/23/2004	US20040259766 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
12/23/2004	US20040259202 Novel angiogenesis inhibitor
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258730 Sustained relase film comprises (11Apha ,13E,15 alpha )-9-oxo-11,15-dihydroxy-16-(3-methoxymethylphenyl)-17,18,19,20-tetranor-5-thiaprost-13-enoic acid methyl ester to treat bone mass disorders; osteoporosis, metastatic bone, hypercalcemia, and Paget's disease
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	DE10325049A1 New peptide derivatives containing cell-adhesion molecule and phosphonate-containing anchor component, useful for treating disorders associated with implants, are inhibitors of integrins
12/23/2004	CA2570398A1 Assessment of skeletal growth using measurements of nt-cnp peptides
12/23/2004	CA2529806A1 Diphenylurea derivatives and their use as chloride channel blockers
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases
12/23/2004	CA2528235A1 Connective tissue derived polypeptides
12/23/2004	CA2526041A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3
12/22/2004	EP1489187A1 Osteoclast differentiation inhibitors
12/22/2004	EP1489172A1 Nuclear receptor err gamma 3
12/22/2004	EP1489083A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
12/22/2004	EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
12/22/2004	EP1489076A1 Cyclic hemiacetal derivative and use thereof
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1488790A1 Solid preparation containing single crystal form
12/22/2004	EP1488787A1 Topical stabilized formulations containing ketoprofen
12/22/2004	EP1487865A2 USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS
12/22/2004	EP1487843A2 Substituted phenylacetic acids
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487541A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487480A2 Fusion molecules and methods for treatment of immune diseases
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1487444A1 Use of pyridyl amides as inhibitors of angiogenesis
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1487273A1 Compositions and methods for treatment of microbial infections
12/22/2004	EP1453949A4 Production of cell suspensions
12/22/2004	EP1436266A4 Methods and compositions of novel triazine compounds
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1274408B1 Use of natural chrysanthone compounds having antiangiogenic activity
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	CN1556853A Probiotics lactobacillus casei bacterial strain
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2004	CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004	CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme
12/22/2004	CN1556795A 3-desoxy-vitamin D3 analog esters
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1555881A Preparation method of wind damp sinew bone plaster
12/22/2004	CN1555880A Knoks and falls bone connecting plaster preparation method
12/22/2004	CN1555879A Malus spectabilis snake lice pill
12/22/2004	CN1555876A Chinese herbal medicinal preparation for curing sinew bone disease
12/22/2004	CN1555874A Medicine for treating protrasion of lumbar intervertabral disc
12/22/2004	CN1555857A Medicinal plaster for treating sinew and bone tissue injury pain, bone fracture, dislocation
12/22/2004	CN1555842A Chinese medicine for expelling stasis
12/22/2004	CN1555841A Chinese medicinal capsule for kidney supplementing blood quickening and bones and muscles strengthening and its preparation method
12/22/2004	CN1555838A Osteosis powder plaster externel use Chinese medicine
12/22/2004	CN1555828A Bone strengthening marrow fortifing pill for treating osteoporosis comprehensive syndrome and its preparation method
12/22/2004	CN1555824A Neck plaster
12/22/2004	CN1555818A External use medicine for treating bone ulcer and its preparation method
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/22/2004	CN1180846C Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
12/22/2004	CN1180841C Method to enhance healing of sternum after sternotomy
12/22/2004	CN1180837C Plaster for treating lumbar vertebra osteoproliferation
12/22/2004	CN1180831C New preparation of compound Chinese medicine for treating osteoarthritis
12/22/2004	CN1180827C Ointment for treating nuchal rigidity
12/22/2004	CN1180819C Chinese medicine composition for treating prolapse of lumbar intervertebral disc and sciatica
12/22/2004	CN1180816C Liniment for treating rheumarthritis and similar diseases and its prepn process
12/22/2004	CN1180814C Chinese medicine pill for treatment of rheumatism and atrophic arthritis
12/22/2004	CN1180812C Chinese medicine composition for treating tetanic rachitis complicated necrosis of femoral head
12/22/2004	CN1180802C Medicine for external application for curing traumatic injury
12/22/2004	CN1180798C Chinese patent medicine for treating lumbocrural pain and Woman's wind sieases during pregnancy and post partum
12/22/2004	CN1180797C Medicine for preventing and curing osteoporosis
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833372 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin

1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 820